Nutrition Research
Volume 30, Issue 1 , Pages 1-13 , January 2010

Antidiabetic effects of fermented soybean products on type 2 diabetes

  • Dae Young Kwon

      Affiliations

    • Emerging Innovative Technology Research Division, Korean Food Research Institutes, Sungnam
    • ,
  • James W. Daily III

      Affiliations

    • Daily Manufacturing Inc., Rockwell, NC, USA
    • ,
  • Hyun Jin Kim

      Affiliations

    • Emerging Innovative Technology Research Division, Korean Food Research Institutes, Sungnam
    • ,
  • Sunmin Park

      Affiliations

    • Department of Food and Nutrition, Obesity/Diabetes Research Institutes, Hoseo University, Asan
    • Corresponding Author InformationCorresponding author. Department of Food and Nutrition, Hoseo University, Chungnam-Do 336-795, Korea. Tel.: +82 41 540 5633; fax: +82 41 548 0670.

Received 30 September 2009 ,Revised 12 November 2009 ,Accepted 15 November 2009.

References 

  1. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787–835
  2. Kaiser N, Leibowitz G. Failure of beta-cell adaptation in type 2 diabetes: lessons from animal models. Front Biosci. 2009;14:1099–1115
  3. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53:S16–S21
  4. Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab. 2007;3:758–768
  5. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110
  6. Messina M. Soy, soy phytoestrogens (isoflavones), and breast cancer. Am J Clin Nutr. 1999;70:574–575
  7. Davis J, Iqbal MJ, Steinle J, Oitker J, Higginbotham DA, Peterson RG, et al. Soy protein influences the development of the metabolic syndrome in male obese ZDFxSHHF rats. Horm Metab Res. 2005;37:316–325
  8. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002;76:1191–1201
  9. Choi SB, Jang JS, Park S. Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology. 2005;146:4786–4794
  10. Villegas R, Gao YT, Yang G, Li HL, Elasy TA, Zheng W, et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008;87:162–167
  11. Garcia MC, Torre M, Marina ML, Laborda F. Composition and characterization of soybean and related products. Crit Rev Food Sci Nutr. 1997;37:361–391
  12. Kwon DY, Kim S, Kim HYL, Kim KS. Changes in physicochemical properties of glycinin due to maleylation. Food Sci Biotechnol. 2003;12:122–127
  13. Kwon DY, Oh SW, Lee JS, Yang HJ, Lee SH, Lee JH, et al. Amino acid substitution of hypocholesterolemic peptide originated from glycinin hydrolyzate. Food Sci Biotechnol. 2002;11:55–61
  14. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc. 1991;91:828–835
  15. Velasquez MT, Bhathena SJ. Role of dietary soy protein in obesity. Int J Med Sci. 2007;4:72–82
  16. Murphy P, Song T, Buseman G, Barua K, Beecher G, Trainer D, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem. 1999;47:2697–2704
  17. Lee YW, Kim JD, Zheng J, Row KH. Comparisons of isoflavones from Korean and Chinese soybean and processed products. Biochem Eng J. 2007;36:49–53
  18. Jang CH, Park CS, Lim JK, Kim JH, Kwon DY, Kim YS, et al. Metabolism of isoflavone derivatives during manufacturing of traditional meju and doenjang. Food Sci Biotechnol. 2008;17:442–445
  19. Nakajima N, Nozaki N, Ishihara K, Ishikawa A, Tsuji H. Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh. J Biosci Bioeng. 2005;100:685–687
  20. Yamabe S, Kobayashi-Hattori K, Kaneko K, Endo K, Takita T. Effect of soybean varieties on the content and composition of isoflavone in rice-koji miso. Food Chem. 2007;100:369–374
  21. Reddy NR, Piersoon MD, Salunkhe DK. In: Legume-based fermented foods. Boca Raton: CRC Press; 1986;p. 47–118
  22. Beak LM, Park LY, Park KS, Lee SH. Effect of starter cultures on the fermentative characteristics of cheonggukjang. Korean J Food Sci Technol. 2008;40:400–405
  23. Park JS, Lee MY, Kim JS, Lee TS. Compositions of nitrogen compound and amino acid in soybean paste (Doenjang) prepared with different microbial sources. Korean J Food Sci Technol. 1994;26:609–615
  24. Sparringa RA, Owens JS. Protein utilization during soybean tempeh fermentation. J Agric Food Chem. 1999;47:4375–4378
  25. Kada S, Yabusaki M, Kaga T, Ashida H, Yoshida K. Identification of two major ammonia-releasing reactions involved in secondary fermentation. Biosci Biotechnol Biochem. 2008;72:1869–1876
  26. Barnes S, Coward L, Kirk M, Sfakianos J. HPLC–mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med. 1998;217:254–262
  27. Choi HK, Yoon JH, Kim YS, Kwon DY. Metabolomic profiling of cheonggukjang during fermentation by 1H NMR spectrometry and principal components analysis. Process Biochem. 2007;42:263–266
  28. Kim KS, Kim MJ, Park JS, Sohn HS, Kwon DY. Compositions of functional components of traditional Korean soybeans. Food Sci Biotechnol. 2003;12:157–160
  29. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Makoto S, et al. Soy isoflavones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr. 2000;130:1695–1698
  30. Lee BY, Kim DM, Kim KH. Physico-chemical properties of viscous substance extracted from chungkook-jang. Korean J Food Sci Technol. 1991;23:599–604
  31. Lee KS, Lee JC, Lee JK, Hwang ES, Lee SS, Oh MJ. Quality of 4-recommended soybean cultivars for meju and doenjang. Korean J Food Preserv. 2002;9:205–211
  32. USDA . USDA national nutrient database for standard reference. http://www.nal.usda.gov/fnic/foodcomp/search/
  33. Yang SO, Kim MS, Liu KH, Auh JH, Kim YS, Kwon DY, et al. Classification of fermented soybean paste during fermentation by 1H nuclear magnetic resonance spectroscopy and principal component analysis. Biosci Biotechnol Biochem. 2009;73:502–507
  34. Piskula MK, Yamakoshi J, Yukihiko I. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Letters. 1999;447:287–291
  35. Wang HJ, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem. 1994;42:1666–1673
  36. King RA, Broadbent JL, Head RJ. Absorption and excretion of the soy isoflavones genistein in rats. J Nutr. 1996;126:176–182
  37. Zubik L, Meydani M. Bioavailability of soybean isoflavones from aglycones and glucoside forms in American women. Am J Clin Nutr. 2003;77:1459–1465
  38. Rüfer CE, Bub A, Möseneder , Winterhalter P, Störtz M, Kulling SE. Pharmacokinetis of the soybean isoflavones daidzein in its aglycones and glucoside form: a randomized, double-blind, crossover study. Am J Clin Nutr. 2008;87:1314–1323
  39. Gardner CD, Chatterjee LM, Franke AA. Effects of isoflavones supplements vs. soy foods on blood concentrations of genistein and daidzein in adults. J Nutr Biochem. 2008;20:227–234
  40. Xia X, Wang HJ, Murphy PA, Hendrich S. Neither background diet nor type of soy food affects short-term isoflavones bioavailability in women. J Nutr. 2000;130:798–801
  41. Chanteranne B, Branca F, Kaardinal A, Braesco V, Ladroite P, Brouns F, et al. Food matrix and isoflavones bioavailability in early post menopausal: a clinical European study. Clin Interv Aging. 2008;3:711–718
  42. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr. 2003;133:1027–1035
  43. Vergne S, Bennetau-Pelissero C, Lamothe V, Chantre P, Potier M, Asselineau J, et al. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young health males. Br J Nutr. 2008;99:333–344
  44. Raimondi S, Roncaglia L, De Lucia M, Amaretti A, Leonardi A, Pagoni UM, et al. Bioconversion of soy isoflavones daidzin and daidzein by Bifobacterium strains. Appl Microbiol Biotechnol. 2009;81:943–950
  45. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. Bioavailability of soybean isflavones depends upon gut microflora in women. J Nutr. 1995;125:2307–2315
  46. Nielsen ILF, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer. 2007;57:1–10
  47. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, et al. Equol, a metabolit of daidzein, inhibits bone loss in ovariectomized mice. J Nutr. 2004;134:2623–2627
  48. Gonzalez S, Jayagopal V, Kilpatrick ES, Chapman T, Atkin SL. Effects of isoflavones dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2007;30:1871–1873
  49. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol—a clue to the effectiveness of soy isflavones. J Nutr. 2002;132:3577–3584
  50. Halm BM, Ashburn LS, Franke AA. Isoflavones from soya foods are more bioavailable in children than adults. Br J Nutr. 2007;98:998–1005
  51. Franke AA, Halm BM, Ashburn LA. Isoflavones in children and adults consuming soy. Arch Biochem Biophys. 2008;15:161–170
  52. Lioe HN, Apriyantono A, Takara K, Wada K, Naoik H, Yasuda M. Low molecular weight compounds responsible for savory taste of Indonesian soy sauce. J Agric Food Chem. 2004;52:5950–5956
  53. Aaslyng MD, Martens M, Poll L, Nielsen PM, Flyge H, Larsen LM. Chemical and sensory characterization of hydrolyzed vegetable protein, a savory flavoring. J Agric Food Chem. 1998;46:481–489
  54. Sites CK, Cooper BC, Toth MJ, Gastaldelli A, Arabshahi A, Barnes S. Effect of daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril. 2007;88:1609–1617
  55. Galvez AF, Chen N, Macasieb J, de Lumen BO. Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibits acetyation. Cancer Res. 2001;61:7473–7478
  56. Park JH, Jeong HJ, Lumen BO. In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI. J Agric Food Chem. 2007;55:10703–10706
  57. Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage. Peptides. 2009;[online publication]
  58. Inoue K, Gotou T, Kitajima H, Mizuno S, Nakazawa T, Yamamoto N. Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein. J Biosci Bioeng. 2009;108:111–115
  59. Kim SH, Lee YJ, Kwon DY. Isolation of angiotensin converting enzyme inhibitor from doenjang. Korean J Food Sci Technol. 1999;31:848–854
  60. Shimizu M, Son DO. Food-derived peptides and intestinal functions. Curr Pharm Design. 2007;13:885–895
  61. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 1998;391:900–904
  62. Milburn JL, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, et al. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem. 1995;270:1295–1299
  63. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem. 1996;271:5633–5637
  64. Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest. 2004;114:828–836
  65. González C, Alonso A, Grueso NA, Díaz F, Esteban MM, Fernández S, et al. Effect of treatment with different doses of 17β-estradiol on insulin receptor substrate-1. J Pancreas. 2001;2:140–149
  66. Zethelius B, Hales CN, Lithell HO, Berne C. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care. 2004;27:1433–1438
  67. Brussaard HE, Gevers Leuven JA, Frolich M, Kluft C, Krans HM. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia. 1997;40:843–849
  68. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care. 1998;21:1589–1595
  69. Brown MD, Korytkowski MT, Zmuda JM, McCole SD, Moore GE, Hagberg JM. Insulin sensitivity in postmenopausal women. Diabetes Care. 2000;23:1731–1736
  70. Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care. 2002;25:127–133
  71. Ferrannini E, Camastra S, Gastaldelli A, Maria Sironi A, Natali A, Muscelli E, et al. Beta-cell function in obesity: effects of weight loss. Diabetes. 2004;53:S26–33
  72. Kimura M, Irahara M, Yasui T, Saito S, Tezuka M, Yamano S, et al. The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain. Biochem Biophys Res Comm. 2002;290:1349–1353
  73. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology. 2001;142:3546–3553
  74. Simkin-Silverman LR, Wing RR. Weight gain during menopause: is it inevitable or can it be prevented?. Postgrad Med J. 2000;108:47–50
  75. Sutter-Dub M. Preliminary report: effects of female sex hormones on insulin secretion by the perfused rat pancreas. J Physiol Paris. 1976;72:795–800
  76. Nadal J, Rovira M, Laribi O, Leon-Quinto T, Andreu E, Ripoll C, et al. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J. 1998;12:1341–1348
  77. Ropero AB, Fuentes E, Rovira JM, Ripoll C, Soria B, Nadal A. Non-genomic actions of 17β-oestradiol in mouse pancreatic β-cells are mediated by a cGMP-dependent protein kinase. J Physiol (Lond). 1999;521:397–407
  78. White MF. The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem. 1998;182:3–11
  79. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 2003;17:1575–1580
  80. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr. 2003;133:1238–1243
  81. Ishihara K, Oyaizu S, Fukuchi Y, Mizunoya W, Segawa K, Takahashi M, et al. A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice. J Nutr. 2003;133:752–757
  82. Sites CK, Cooper BC, Toth MJ, Gastaldelli A, Arabshahi A, Barnes S. Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril. 2007;88:1609–1617
  83. González S, Jayagopal V, Kilpatrick ES, Chapman T, Atkin SL. Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2007;30:1871–1873
  84. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol. 1996;87:897–904
  85. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology. 1998;139:4252–4263
  86. Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab. 1998;83:297–303
  87. Lemieux C, Gélinas Y, Lalonde J, Labrie F, Richard D, Deshaies Y. The selective estrogen receptor modulator acolbifene reduces cholesterolemia independently of its anorectic action in control and cholesterol-fed rats. J Nutr. 2005;135:2225–2229
  88. Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr. 2009;139:1700–1706
  89. Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K. Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem. 2008;56:4377–4385
  90. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 2008;31:648–654
  91. Trujillo J, Ramírez V, Pérez J, Torre-Villalvazo I, Torres N, Tovar AR, et al. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol. 2005;288:F108–116
  92. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr. 2004;134:1874–1880
  93. Lu MP, Wang R, Song X, Chibbar R, Wang X, Wu L, et al. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr Res. 2008;28:464–471
  94. Cederroth CR, Vinciguerra M, Gjinovci A, Kühne F, Klein M, Cederroth M, et al. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes. 2008;57:1176–1185
  95. Nikander E, Tiitinen A, Laitinen K, Tikkanen M, Ylikorkala O. Effects of isolated isoflavonoids on lipids, lipoproteins, insulin sensitivity, and ghrelin in postmenopausal women. J Clin Endocrinol Metab. 2004;89:3567–3572
  96. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause. 2001;8:259–265
  97. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr. 2001;131:1202–1206
  98. Noriega-López L, Tovar AR, Gonzalez-Granillo M, Hernández-Pando R, Escalante B, Santillán-Doherty P, et al. Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem. 2007;282:20657–20666
  99. Ronis MJ, Chen Y, Badeaux J, Badger TM. Dietary soy protein isolate attenuates metabolic syndrome in rats via effects on PPAR, LXR, and SREBP signaling. J Nutr. 2009;139:1431–1438
  100. Veloso RV, Latorraca MQ, Arantes VC, Reis MA, Ferreira F, Boschero AC, et al. Soybean diet improves insulin secretion through activation of cAMP/PKA pathway in rats. J Nutr Biochem. 2008;19:778–784
  101. Taniguchi A, Yamanaka-Okumura H, Nishida Y, Yamamoto H, Taketani Y, Takeda E. Natto and viscous vegetables in a Japanese style meal suppress postprandial glucose and insulin responses. Asia Pac J Clin Nutr. 2008;17:663–668
  102. Kwon DY, Hong SM, Ahn IS, Kim YS, Shin DW, Park S. Kochujang, a Korean fermented red pepper plus soybean paste, improves glucose homeostasis in 90% pancreatectomized diabetic rats. Nutrition. 2009;25:790–799
  103. Kawakami Y, Tsurugasaki W, Nakamura S, Osada K. Comparison of regulative functions between dietary soy isoflavones aglycone and glucoside on lipid metabolism in rats fed cholesterol. J Nutr Biochem. 2005;16:205–212
  104. Kwon DY, Jang JS, Hong SM, Lee JE, Sung SR, Park HR, et al. Long-term consumption of fermented soybean-derived Chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rats. Eur J Nutr. 2007;46:44–52
  105. Kwon DY, Hong SM, Lee JE, Sung SR, Park S. Long-term consumption of fermented soybean-derived Chungkookjang attenuates hepatic insulin resistance in 90% pancreatectomized diabetic rats. Horm Metab Res. 2007;39:752–757
  106. Fujita H, Yamagami T. Fermented soybean-derived Touchi-extract with anti-diabetic effect via alpha-glucosidase inhibitory action in a long-term administration study with KKAy mice. Life Sci. 2001;70:219–227
  107. Fujita H, Yamagami T, Ohshima K. Long-term ingestion of a fermented soybean-derived Touchi-extract with alpha-glucosidase inhibitory activity is safe and effective in humans with borderline and mild type-2 diabetes. J Nutr. 2001;131:2105–2108
  108. Kim DJ, Jeong YJ, Kwon JH, Moon KD, Kim HJ, Jeon SM, et al. Beneficial effect of chungkukjang on regulating blood glucose and pancreatic beta-cell functions in C75BL/KsJ-db/db mice. J Med Food. 2008;11:215–223
  109. Kwon DY, Jang JS, Lee JE, Kim YS, Shin DW, Park S. The isoflavonoid aglycone-rich fractions of Chungkookjang, fermented unsalted soybeans, enhance insulin signaling and peroxisome proliferator-activated receptor-γ activity in vitro. Biofactors. 2006;26:245–258
  110. Jung KO, Park SY, Park KY. Longer aging time increases the anticancer and antimetastatic properties of doenjang. Nutrition. 2006;22:539–545
  111. Karlsson S, Scheurink AJ, Steffens AB, Ahrén B. Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice. Am J Physiol. 1994;267:R1071–R1077
  112. Diepvens K, Westerterp KR, Westerterp-Plantenga MS. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol. 2007;292:R77–85
  113. Choi YM, Suh HJ. Pharmacological effects of fermented red pepper. Phytother Res. 2004;18:884–888

PII: S0271-5317(09)00245-0

doi: 10.1016/j.nutres.2009.11.004

Nutrition Research
Volume 30, Issue 1 , Pages 1-13 , January 2010

Article Tools

* Image Usage & Resolution